{"name":"BioInvent International AB","slug":"bioinvent-international-ab","ticker":"","exchange":"","domain":"","description":"BioInvent International AB is a clinical-stage biotechnology company focused on the discovery and development of novel antibody-based therapies for cancer. The company's pipeline includes several candidates in early-stage clinical trials, leveraging its proprietary technology platforms to address significant unmet medical needs.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOcXhkVXBKVFYzQV8wNUpydVBOVlBRekEtMmJwVXdQZjJIbGhRTkZ5WnpQbmdPS1ROZHF0MzF1SVlneXJ2ZWNDR3V2NGdTaWNUNFY3R1FscEQzRVd2azhBTjI1ZzFKQVZyWHZpMDZfemJFZHY3bVdNUEM3Ni10ZUs2Y0pPc0JvbFlGOFZWZW1oZjBDQXdZU3NuQmlrbWFzUXBBYnV3Y0hMMWt3b29mQVRaQXZR?oc=5","date":"2026-03-31","type":"pipeline","source":"Yahoo Finance","summary":"BioInvent International AB Publishes Annual Report 2025 - Yahoo Finance","headline":"BioInvent International AB Publishes Annual Report 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNZkZBdEZjejFDaHJFWlRhOGFaY0N6UlBNZjhLN2NLVWZ1WlRpRjhrYmdPZzRhSWpRV0ZQT0E4QXBfWm9LeWhveU40MHpUX1hzN09GR3k2NnE0TlBLQ0Z2cjJEQlpwYWZkakpTOW5lSldnYWY0RGtYclU4Zmo3NWRWcHc3Z3NXd3F1Ullz?oc=5","date":"2026-02-25","type":"pipeline","source":"Yahoo Finance","summary":"BioInvent International AB: Year-End Report January 1 - December 31, 2025 - Yahoo Finance","headline":"BioInvent International AB: Year-End Report January 1 - December 31, 2025","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-30","type":"pipeline","source":"simplywall.st","summary":"BioInvent International AB (publ) (STO:BINV): When Will It Breakeven? - simplywall.st","headline":"BioInvent International AB (publ) (STO:BINV): When Will It Breakeven?","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-09","type":"pipeline","source":"simplywall.st","summary":"Investors Don't See Light At End Of BioInvent International AB (publ)'s (STO:BINV) Tunnel And Push Stock Down 26% - simplywall.st","headline":"Investors Don't See Light At End Of BioInvent International AB (publ)'s (STO:BINV) Tunnel And Push Stock Down 26%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQRXlSR1Z1blpJX0stQ0VkWHYtTHNja1ZrRmx0TDRUQ0pYVndXLWNkUWVONGJFV1duODQ3VS1kdkVVeFVoMEc4ZVNUa2RORklYeFVYSnZjSXZiU1h2ZXlrT0pKSUZDSHdNSGdWRGVIM1AyLTY0ZlVEVmJkLXdpY2JWR2t0cjRrSWlzbGw0YndkZ09HYVJEZkJ3a3ZMeW1XQTJTQnVDM1k0SWNTZnlPUUhTQkt0RThlUE04NVJkR0FRMmpQY3kyRHUw?oc=5","date":"2024-04-23","type":"pipeline","source":"Cambridge Network","summary":"Calluna Pharma appoints Margrethe Sørgaard as Senior Vice President of Clinical Operations and Pharmacovigilance - Cambridge Network","headline":"Calluna Pharma appoints Margrethe Sørgaard as Senior Vice President of Clinical Operations and Pharmacovigilance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNMnEwRk9UZmlHYWIwQVFhNXIyZHJYQl9BNUVHNnlPNXRaZXZsNnE4TElNOTF3SG5ubWktNDRuVlo3MjFCd0NCOFBJXzNSMzhLUUVTSUdFWXNDSm1mQjlPcjZ4Tzl2dWJRRnVDc0JjZjNpVUp5cDRuQ2R2b3I3Ynhoel9FT0xycmN6Njk2aFEzQWYzdw?oc=5","date":"2024-01-15","type":"regulatory","source":"openPR.com","summary":"Advanced Merkel Cell Carcinoma Pipeline, FDA Approval, Clinical Trials Development and Companies (Updated) - openPR.com","headline":"Advanced Merkel Cell Carcinoma Pipeline, FDA Approval, Clinical Trials Development and Companies (Updated)","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOM1NRQkU0ZV8xeE4wdXpoaDkxdFJlODRuSEVhVXFNWE9tYnNmOUFCdHhnT05Ma3UwY3FSVEtqb19TaUI3YnFfNFdfd2Q0WWUxQmtvQkFKbEVJa0dhbFlCVVhpVkE4ODFwaWs0dk1BTUZxLWk5Q2dVamxaZzh1cDNDUEl1Y2VYYnNJZGtNOVNOSHlXT2dpeUdOeGxIdUc?oc=5","date":"2022-10-27","type":"pipeline","source":"Yahoo Finance France","summary":"BioInvent International AB: Interim report January-September 2022 - Yahoo Finance France","headline":"BioInvent International AB: Interim report January-September 2022","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPTkVfY2Z6WGYtTHdqWF82bXI0N28wZkhvdkd3YnRjZGpXR3BadkRmVC1LelAzMnhEU1pfOXBOYzVNbTZKQmxldlgyN2owR3k2NnFESnJ4TWRkNi1Ja1haR2tkLWVQdTA5cWF3dTNpdnlac21vZmhUeVE3RGxVU1kyY0tzbW1Gai1PUkhSOU9sN0NDY19DVzNJVHltMW5YVkVQSVc4?oc=5","date":"2020-05-04","type":"pipeline","source":"Contract Pharma","summary":"BioInvent Signs Manufacturing Agreement - Contract Pharma","headline":"BioInvent Signs Manufacturing Agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE5wb3BRMngtdHhNRUZyNGJmNS1zX1NwWDRpR1FMaV9NS1Q3c083eUMyZ1BObWhfQW1pazV0aHhKNXRYLURGMUFkdy1kQV9QbDBuTGpmUg?oc=5","date":"2017-05-13","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Moberg Pharma AB (publ) (MOB.ST) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Moberg Pharma AB (publ) (MOB.ST) stock price, news, quote and history","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}